The metabolic syndrome and early kidney disease: Another link in the chain?;El síndrome metabólico y la enfermedad renal temprana: ¿Un eslabón más de la cadena?

Revista Espanola de Cardiologia

Volumn 64, Issue 5, 2011, Pages 358-360

  Lerman, Lilach O ^a   Lerman, Amir ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE ASSOCIATION; EDITORIAL; KIDNEY DISEASE; METABOLIC SYNDROME X;

EID: 79955624713     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2011.01.005     Document Type: Article

References (16)

1. National Heart, Lung, and Blood Institute: Diseases and Conditions Index. What is metabolic syndrome? [consultado 1/2010]. Disponible en: http://www.nhlbi.nih.gov/health/dci/Diseases/ms/ms-whatis.html
2. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-9. (Pubitemid 34251969)
3. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709-16. (Pubitemid 35403784)
4. Hall JE, Crook ED, Jones DW,Wofford MR, Dubbert PM. Mechanisms of obesity-associated cardiovascular and renal disease. Am J Med Sci. 2002;324:127-37.
5. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, et al. The metabolic syndrome. Endocr Rev. 2008;29:777-822.
6. Birnbaum HG, Mattson ME, Kashima S, Williamson TE. Prevalence rates and costs of metabolic syndrome and associated risk factors using employees' integrated laboratory data and health care claims. J Occup Environ Med. 2011;53:27-33.
7. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28:629-36. (Pubitemid 351651324)
8. Agrawal V, Shah A, Rice C, Franklin BA, McCullough PA. Impact of treating the metabolic syndrome on chronic kidney disease. Nat Rev Nephrol. 2009;5:520-8.
9. Navaneethan SD, Schold JD, Srinivas TR. Metabolic syndrome and mild to moderate chronic kidney disease among minorities. Semin Nephrol. 2010;30:51-8.
10. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004;140:167-74.
11. Ritz E. Kidney damage in metabolic syndrome: nip it in the bud. Am J Kidney Dis. 2009;53:726-9.
12. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S76-S110.
13. Tonelli M, Muntner P, Lloyd A, Manns BJ, James MT, Klarenbach S, et al. Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort study. Ann Intern Med. 2011;154:12-21.
14. James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet. 2010;375:1296-309.
15. Landecho MF, Colina I, Huerta A, Fortuño A, Zalba G, Beloqui O. Relación entre las fases precoces de la enfermedad renal y el síndrome metabólico. Rev Esp Cardiol. 2011;64:373-8.
16. Khera AV, Cuchel M, De la Llera-Moya M, Rodrigues A, Burke MF, Jafri K, et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med. 2011;364:127-35.